Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

BPOM Wants People to Stop Promoting Ivermectin as Covid-19 Drug

23 July 2021 12:00 WIB

Ivermectin. shutterstock.com

TEMPO.CO, Jakarta - The Food and Drugs Monitoring Agency (BPOM) cautioned stakeholders, including pharmaceutical firms that produce Ivermectin, to stop promoting the medicine as a therapeutic drug for Covid-19 as the agency has not yet authorized the use of the drug. 

“Ivermectin is a potent drug and the expanded access program (EAP) is not a distribution permit approval, which is why we encourage pharmaceutical industry producing the drug and anyone to not promote the drug,” the BPOM website wrote on Wednesday, July 21. 

This drug, BPOM stated, is classified as a drug that allegedly has potency to fight against Covid-19. But it needs further evidence through clinical trials which is being held by the Health Ministry’s policy review agency.

The wider use of the drug by the Health Ministry and healthcare facilities must get the approval from the BPOM that will later be included in the EAP scheme. A drug is acknowledged as an EAP drug when the health governing body deems it necessary to be used under an emergency situation. 

BPOM previously issued a technical guideline of the use of the drugs under the Expanded Access Program. 

Read: BPOM Issues Rule on Expanded Access Program for Ivermectin

CAESAR AKBAR



Police Thwart Drug Smuggling Attempt from China

2 hari lalu

Police Thwart Drug Smuggling Attempt from China

The China-based international network smuggled the illicit goods into three jars of energy drinks.


U.S. FDA Approves First Drug for Fatty Liver Disease NASH

14 hari lalu

U.S. FDA Approves First Drug for Fatty Liver Disease NASH

The U.S. FDA has approved Madrigal Pharmaceuticals' (MDGL.O), drug for a fatty liver disease known as non-alcoholic steatohepatitis (NASH).


Indonesian Customs Destroys 1 Ton of Milk Buns from Thailand

18 hari lalu

Indonesian Customs Destroys 1 Ton of Milk Buns from Thailand

The Customs and Excise Office at Soekarno-Hatta Airport together with BPOM destroyed 2,564 packs of milk buns from Thailand.


Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

21 hari lalu

Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

The recovery in the aviation sector post-COVID-19 pandemic has reached 83 percent.


3 Suspected Drug Traffickers Nabbed in West Aceh's Meulaboh

25 hari lalu

3 Suspected Drug Traffickers Nabbed in West Aceh's Meulaboh

West Aceh police have arrested three suspected drug traffickers with 40 packs of dried marijuana that they attempted to sell in Meulaboh city, Aceh.


How India's COVID Lockdowns Impacted Menstrual Health

34 hari lalu

How India's COVID Lockdowns Impacted Menstrual Health

Limited access to period products during India's COVID lockdown highlighted how far public health initiatives have to go when it comes to menstruation


How Do You Eliminate or Eradicate an Infectious Disease?

34 hari lalu

How Do You Eliminate or Eradicate an Infectious Disease?

The COVID-19 pandemic gave the world a crash course in epidemiology and showed in real time how an infectious disease can spread or be contained.


Why Have Efforts to Eradicate TB Been So Slow?

37 hari lalu

Why Have Efforts to Eradicate TB Been So Slow?

Tuberculosis (TB) is one of the world's most deadly infectious diseases - but the COVID-19 pandemic dramatically slowed efforts to eliminate it.


BPOM Estimated Antimicrobial Resistance to Cause 10 Million Deaths by 2050

52 hari lalu

BPOM Estimated Antimicrobial Resistance to Cause 10 Million Deaths by 2050

BPOM estimated that by 2050, 10 million deaths each year are possible due to antimicrobial resistance or AMR.


Depok Records 200% Hike in COvid-19 Cases Last December

3 Januari 2024

Depok Records 200% Hike in COvid-19 Cases Last December

Depok Mayor Mohammad Idris revealed that the number of Covid-19 cases in the city surged from 100 to 300 as of December 2023